Cargando…

Comparative efficacy of topical tetraVisc versus lidocaine gel in cataract surgery

BACKGROUND: To compare the clinical efficacy of lidocaine 2% with tetracaine 0.5% for cataract surgery. METHODS: In a randomized, multi-surgeon, controlled clinical trial,122 consecutive cataract cases eligible for topical anesthesia, were randomly assigned to receive lidocaine 2% gel (1 ml) or tetr...

Descripción completa

Detalles Bibliográficos
Autores principales: Chalam, KV, Murthy, Ravi K, Agarwal, Swati, Gupta, Shailesh K, Grover, Sandeep
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2736919/
https://www.ncbi.nlm.nih.gov/pubmed/19686592
http://dx.doi.org/10.1186/1471-2415-9-7
_version_ 1782171376316055552
author Chalam, KV
Murthy, Ravi K
Agarwal, Swati
Gupta, Shailesh K
Grover, Sandeep
author_facet Chalam, KV
Murthy, Ravi K
Agarwal, Swati
Gupta, Shailesh K
Grover, Sandeep
author_sort Chalam, KV
collection PubMed
description BACKGROUND: To compare the clinical efficacy of lidocaine 2% with tetracaine 0.5% for cataract surgery. METHODS: In a randomized, multi-surgeon, controlled clinical trial,122 consecutive cataract cases eligible for topical anesthesia, were randomly assigned to receive lidocaine 2% gel (1 ml) or tetracaine solution 0.5% (TetraVisc, 0.5 ml) before clear corneal phacoemulsification. Main outcome measure was visual analog scale (0 to 10), which was used to measure intra-operative pain. Secondary outcome measures included patients' discomfort due to tissue manipulation and surgeon graded patients' cooperation. Duration of surgery and intra-operative complications were also recorded. RESULTS: The mean age in TetraVisc (TV) group was 70.4 years and in the lidocaine gel group (LG) it was 70.6 years (p = 0.89). Patient reported mean intra-operative pain scores by visual analog scale were 0.70 ± 0.31 in TV group and 1.8 ± 0.4 in LG group (P < 0.001). Mean patient cooperation was also marginally better in the TV group (8.3 ± 0.3) compared to LG group (8.4 ± 0.6) (P = 0.25). 96% of patients in TV group showed intra-operative corneal clarity compared to 91% in LG group. TV group had less (1 out of 61 patients, 1.6%) intra-operative complications than LG group (3 out of 61 patients, 4.8%). No anesthesia related complications were noted in either group CONCLUSION: Topical TetraVisc solution was superior to lidocaine 2% gel for pain control in patients undergoing clear corneal phacoemulsification. Lidocaine 2% gel is similar to TetraVisc in patient comfort and surgeon satisfaction. TRIAL REGISTRATION: Clinical trials number: ISRCTN78374774
format Text
id pubmed-2736919
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-27369192009-09-03 Comparative efficacy of topical tetraVisc versus lidocaine gel in cataract surgery Chalam, KV Murthy, Ravi K Agarwal, Swati Gupta, Shailesh K Grover, Sandeep BMC Ophthalmol Research Article BACKGROUND: To compare the clinical efficacy of lidocaine 2% with tetracaine 0.5% for cataract surgery. METHODS: In a randomized, multi-surgeon, controlled clinical trial,122 consecutive cataract cases eligible for topical anesthesia, were randomly assigned to receive lidocaine 2% gel (1 ml) or tetracaine solution 0.5% (TetraVisc, 0.5 ml) before clear corneal phacoemulsification. Main outcome measure was visual analog scale (0 to 10), which was used to measure intra-operative pain. Secondary outcome measures included patients' discomfort due to tissue manipulation and surgeon graded patients' cooperation. Duration of surgery and intra-operative complications were also recorded. RESULTS: The mean age in TetraVisc (TV) group was 70.4 years and in the lidocaine gel group (LG) it was 70.6 years (p = 0.89). Patient reported mean intra-operative pain scores by visual analog scale were 0.70 ± 0.31 in TV group and 1.8 ± 0.4 in LG group (P < 0.001). Mean patient cooperation was also marginally better in the TV group (8.3 ± 0.3) compared to LG group (8.4 ± 0.6) (P = 0.25). 96% of patients in TV group showed intra-operative corneal clarity compared to 91% in LG group. TV group had less (1 out of 61 patients, 1.6%) intra-operative complications than LG group (3 out of 61 patients, 4.8%). No anesthesia related complications were noted in either group CONCLUSION: Topical TetraVisc solution was superior to lidocaine 2% gel for pain control in patients undergoing clear corneal phacoemulsification. Lidocaine 2% gel is similar to TetraVisc in patient comfort and surgeon satisfaction. TRIAL REGISTRATION: Clinical trials number: ISRCTN78374774 BioMed Central 2009-08-17 /pmc/articles/PMC2736919/ /pubmed/19686592 http://dx.doi.org/10.1186/1471-2415-9-7 Text en Copyright © 2009 Chalam et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Chalam, KV
Murthy, Ravi K
Agarwal, Swati
Gupta, Shailesh K
Grover, Sandeep
Comparative efficacy of topical tetraVisc versus lidocaine gel in cataract surgery
title Comparative efficacy of topical tetraVisc versus lidocaine gel in cataract surgery
title_full Comparative efficacy of topical tetraVisc versus lidocaine gel in cataract surgery
title_fullStr Comparative efficacy of topical tetraVisc versus lidocaine gel in cataract surgery
title_full_unstemmed Comparative efficacy of topical tetraVisc versus lidocaine gel in cataract surgery
title_short Comparative efficacy of topical tetraVisc versus lidocaine gel in cataract surgery
title_sort comparative efficacy of topical tetravisc versus lidocaine gel in cataract surgery
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2736919/
https://www.ncbi.nlm.nih.gov/pubmed/19686592
http://dx.doi.org/10.1186/1471-2415-9-7
work_keys_str_mv AT chalamkv comparativeefficacyoftopicaltetraviscversuslidocainegelincataractsurgery
AT murthyravik comparativeefficacyoftopicaltetraviscversuslidocainegelincataractsurgery
AT agarwalswati comparativeefficacyoftopicaltetraviscversuslidocainegelincataractsurgery
AT guptashaileshk comparativeefficacyoftopicaltetraviscversuslidocainegelincataractsurgery
AT groversandeep comparativeefficacyoftopicaltetraviscversuslidocainegelincataractsurgery